EP0815244A1 - Thermitase variants having decreased adsorption and increased hydrolysis - Google Patents
Thermitase variants having decreased adsorption and increased hydrolysisInfo
- Publication number
- EP0815244A1 EP0815244A1 EP96908663A EP96908663A EP0815244A1 EP 0815244 A1 EP0815244 A1 EP 0815244A1 EP 96908663 A EP96908663 A EP 96908663A EP 96908663 A EP96908663 A EP 96908663A EP 0815244 A1 EP0815244 A1 EP 0815244A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- asn
- amino acid
- substitution occurs
- gly
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108010031354 thermitase Proteins 0.000 title claims abstract description 84
- 238000006460 hydrolysis reaction Methods 0.000 title claims abstract description 22
- 230000007062 hydrolysis Effects 0.000 title claims abstract description 20
- 238000001179 sorption measurement Methods 0.000 title claims abstract description 18
- 230000003247 decreasing effect Effects 0.000 title claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 162
- 238000006467 substitution reaction Methods 0.000 claims abstract description 153
- 238000004140 cleaning Methods 0.000 claims abstract description 121
- 125000003275 alpha amino acid group Chemical class 0.000 claims abstract description 92
- 239000000758 substrate Substances 0.000 claims abstract description 25
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 7
- 102000004190 Enzymes Human genes 0.000 claims description 88
- 108090000790 Enzymes Proteins 0.000 claims description 88
- 239000004744 fabric Substances 0.000 claims description 40
- 239000004094 surface-active agent Substances 0.000 claims description 16
- 238000004851 dishwashing Methods 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 9
- 239000002689 soil Substances 0.000 claims description 8
- 239000002131 composite material Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000004927 clay Substances 0.000 claims description 5
- 239000002304 perfume Substances 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 4
- 239000007844 bleaching agent Substances 0.000 claims description 3
- 239000002270 dispersing agent Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 239000000975 dye Substances 0.000 claims description 2
- 239000002979 fabric softener Substances 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 18
- 102220640248 Mitochondrial 2-oxoglutarate/malate carrier protein_S220E_mutation Human genes 0.000 description 278
- 102220471019 Dual specificity mitogen-activated protein kinase kinase 6_S207E_mutation Human genes 0.000 description 184
- 102220568475 Dual specificity mitogen-activated protein kinase kinase 1_S222D_mutation Human genes 0.000 description 176
- 102220499760 Lysine-tRNA ligase_S207D_mutation Human genes 0.000 description 139
- 102220615455 CCAAT/enhancer-binding protein delta_T217E_mutation Human genes 0.000 description 120
- 102220472856 Potassium voltage-gated channel subfamily KQT member 2_T217D_mutation Human genes 0.000 description 105
- 102220612105 E3 ubiquitin-protein ligase Topors_T224P_mutation Human genes 0.000 description 89
- 102220070318 rs115259839 Human genes 0.000 description 89
- 229940088598 enzyme Drugs 0.000 description 86
- 102220500888 H/ACA ribonucleoprotein complex subunit DKC1_G223D_mutation Human genes 0.000 description 85
- 102200128188 rs121908803 Human genes 0.000 description 83
- 102220480401 H/ACA ribonucleoprotein complex subunit DKC1_L221D_mutation Human genes 0.000 description 79
- 102220576698 Phosphatidylinositol 4-kinase beta_T217Q_mutation Human genes 0.000 description 78
- 102220517754 Heat shock factor protein 1_S216E_mutation Human genes 0.000 description 73
- 102220560783 Neuronal migration protein doublecortin_G223E_mutation Human genes 0.000 description 72
- 102220499467 ADP-ribosylation factor-binding protein GGA3_T217P_mutation Human genes 0.000 description 66
- 102220467381 Acyl-coenzyme A thioesterase MBLAC2_A219E_mutation Human genes 0.000 description 65
- 102220193161 rs1057516090 Human genes 0.000 description 61
- 102220555361 X-box-binding protein 1_T212N_mutation Human genes 0.000 description 59
- 102220473333 Connector enhancer of kinase suppressor of ras 1_S216D_mutation Human genes 0.000 description 58
- 102220066135 rs192628905 Human genes 0.000 description 58
- 102220567220 Ras association domain-containing protein 6_L221D_mutation Human genes 0.000 description 55
- 102220229923 rs1064793247 Human genes 0.000 description 55
- 102220640183 Mitochondrial 2-oxoglutarate/malate carrier protein_T215D_mutation Human genes 0.000 description 53
- 102220223293 rs1060502955 Human genes 0.000 description 52
- 102220222674 rs910355512 Human genes 0.000 description 51
- 102220511748 Dipeptidyl peptidase 1_Y210D_mutation Human genes 0.000 description 50
- 102220640147 Mitochondrial 2-oxoglutarate/malate carrier protein_T224D_mutation Human genes 0.000 description 48
- 102220625749 Protein pelota homolog_L221M_mutation Human genes 0.000 description 48
- 102220267028 rs1554945246 Human genes 0.000 description 48
- 102200061605 rs63750569 Human genes 0.000 description 48
- 102200043618 rs28939677 Human genes 0.000 description 47
- 102220077745 rs879255581 Human genes 0.000 description 45
- 102220513951 Mediator of DNA damage checkpoint protein 1_Y210A_mutation Human genes 0.000 description 43
- 239000002253 acid Substances 0.000 description 42
- 102200041219 rs118203943 Human genes 0.000 description 41
- 102220636392 Protein PALS2_L221G_mutation Human genes 0.000 description 40
- 102200154100 rs45588035 Human genes 0.000 description 40
- 102220474246 Histone-lysine N-methyltransferase 2B_T215N_mutation Human genes 0.000 description 39
- 102220558516 Proteinase-activated receptor 2_Y210L_mutation Human genes 0.000 description 39
- 102220644416 Glycogenin-2_P214G_mutation Human genes 0.000 description 38
- 102220512555 Homeobox protein Nkx-2.1_W208L_mutation Human genes 0.000 description 36
- 102220484493 Tryptase alpha/beta-1_T215S_mutation Human genes 0.000 description 36
- 102220036333 rs587779776 Human genes 0.000 description 36
- 102220339079 rs748026786 Human genes 0.000 description 36
- 230000035772 mutation Effects 0.000 description 35
- 102220289331 rs748026786 Human genes 0.000 description 35
- 102200053639 rs879255237 Human genes 0.000 description 35
- 102200094698 c.661C>G Human genes 0.000 description 34
- 102220516406 UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase 110 kDa subunit_W208E_mutation Human genes 0.000 description 33
- 102220640169 Mitochondrial 2-oxoglutarate/malate carrier protein_T215E_mutation Human genes 0.000 description 31
- 102220574905 Endoglin_L221Q_mutation Human genes 0.000 description 28
- 102200017869 rs387906614 Human genes 0.000 description 28
- 102220512556 Homeobox protein Nkx-2.1_W208S_mutation Human genes 0.000 description 27
- 102220290781 rs1555853906 Human genes 0.000 description 27
- 102220618144 Gamma-interferon-inducible protein 16_Y218A_mutation Human genes 0.000 description 26
- 102220531760 Retinoid-inducible serine carboxypeptidase_Y210H_mutation Human genes 0.000 description 26
- 102220200923 rs1057520583 Human genes 0.000 description 25
- 102220282423 rs1160353919 Human genes 0.000 description 25
- 102220628991 Succinate receptor 1_W208A_mutation Human genes 0.000 description 24
- 102220225158 rs144769597 Human genes 0.000 description 24
- 102220466593 Chitobiosyldiphosphodolichol beta-mannosyltransferase_I209S_mutation Human genes 0.000 description 23
- 239000007788 liquid Substances 0.000 description 22
- 102220481661 Matrilin-3_Y218N_mutation Human genes 0.000 description 21
- 102220126947 rs548449293 Human genes 0.000 description 21
- 102220240495 rs755619001 Human genes 0.000 description 21
- -1 Gin Chemical compound 0.000 description 19
- 102000035195 Peptidases Human genes 0.000 description 19
- 108091005804 Peptidases Proteins 0.000 description 19
- 102220505020 Chymotrypsin-C_I209M_mutation Human genes 0.000 description 18
- 102220519803 Prolyl 4-hydroxylase subunit alpha-1_Y213A_mutation Human genes 0.000 description 18
- 239000004365 Protease Substances 0.000 description 18
- 102220324899 rs1555407906 Human genes 0.000 description 16
- 102220146760 rs376640607 Human genes 0.000 description 16
- 102220615190 Extracellular calcium-sensing receptor_Y218S_mutation Human genes 0.000 description 15
- 102220573168 Tyrosine-protein kinase Fer_I209A_mutation Human genes 0.000 description 15
- 102220093847 rs745808534 Human genes 0.000 description 15
- 102220602134 NACHT, LRR and PYD domains-containing protein 10_I209L_mutation Human genes 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 13
- 239000005289 controlled pore glass Substances 0.000 description 12
- 239000003599 detergent Substances 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 102220197437 rs1057519461 Human genes 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 102220540222 WD repeat and coiled-coil-containing protein_T73S_mutation Human genes 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 108090000787 Subtilisin Proteins 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 102220542865 Presenilins-associated rhomboid-like protein, mitochondrial_S70D_mutation Human genes 0.000 description 6
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 102220281547 rs1555514410 Human genes 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229960004063 propylene glycol Drugs 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 102200080721 rs398122362 Human genes 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- 239000010457 zeolite Substances 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 108090001060 Lipase Proteins 0.000 description 4
- 102000004882 Lipase Human genes 0.000 description 4
- 239000004367 Lipase Substances 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 102220514139 Mediator of DNA damage checkpoint protein 1_G72N_mutation Human genes 0.000 description 4
- 102220551207 Protein FAM50A_W206G_mutation Human genes 0.000 description 4
- 102220472706 Retinoschisin_W206C_mutation Human genes 0.000 description 4
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- 150000008051 alkyl sulfates Chemical class 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000019421 lipase Nutrition 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 102220011019 rs397507513 Human genes 0.000 description 4
- 150000004760 silicates Chemical class 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- JSYPRLVDJYQMAI-ODZAUARKSA-N (z)-but-2-enedioic acid;prop-2-enoic acid Chemical compound OC(=O)C=C.OC(=O)\C=C/C(O)=O JSYPRLVDJYQMAI-ODZAUARKSA-N 0.000 description 3
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 3
- 102220478239 Alpha-endosulfine_S109E_mutation Human genes 0.000 description 3
- 101100533230 Caenorhabditis elegans ser-2 gene Proteins 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 102220530350 Hepatocyte nuclear factor 1-alpha_W206L_mutation Human genes 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- 102220477261 Meiosis 1 arrest protein_T195P_mutation Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102220542207 Probable polypeptide N-acetylgalactosaminyltransferase 8_S192D_mutation Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102220541372 Tyrosyl-DNA phosphodiesterase 1_W206A_mutation Human genes 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 229940106157 cellulase Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000551 dentifrice Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102200093907 rs104894375 Human genes 0.000 description 3
- 102200110904 rs121917881 Human genes 0.000 description 3
- 102220281791 rs904361724 Human genes 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- GZMAAYIALGURDQ-UHFFFAOYSA-N 2-(2-hexoxyethoxy)ethanol Chemical compound CCCCCCOCCOCCO GZMAAYIALGURDQ-UHFFFAOYSA-N 0.000 description 2
- 102220537582 ATP synthase subunit delta, mitochondrial_W206S_mutation Human genes 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 2
- 102220617030 C-type lectin domain family 10 member A_A203G_mutation Human genes 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 206010057248 Cell death Diseases 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102220510033 Importin-7_T111N_mutation Human genes 0.000 description 2
- 102220470056 M-phase inducer phosphatase 3_S191D_mutation Human genes 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- 102220471509 Sarcoma antigen 1_Y216D_mutation Human genes 0.000 description 2
- 102220471511 Sarcoma antigen 1_Y216S_mutation Human genes 0.000 description 2
- 102220509109 Sentrin-specific protease 1_G67V_mutation Human genes 0.000 description 2
- 102220515246 Serum response factor-binding protein 1_T195N_mutation Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 108010056079 Subtilisins Proteins 0.000 description 2
- 102000005158 Subtilisins Human genes 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000004996 alkyl benzenes Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229940077388 benzenesulfonate Drugs 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229910052570 clay Inorganic materials 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 102220199458 rs1057523249 Human genes 0.000 description 2
- 102200060543 rs1060505037 Human genes 0.000 description 2
- 102200130874 rs118204056 Human genes 0.000 description 2
- 102220119544 rs200102936 Human genes 0.000 description 2
- 102200142166 rs35258119 Human genes 0.000 description 2
- 102220020329 rs397508119 Human genes 0.000 description 2
- 102200062430 rs397514559 Human genes 0.000 description 2
- 102220028749 rs398123217 Human genes 0.000 description 2
- 102200047013 rs61752144 Human genes 0.000 description 2
- 102200012398 rs7732671 Human genes 0.000 description 2
- 102220097941 rs876659089 Human genes 0.000 description 2
- 150000003333 secondary alcohols Chemical class 0.000 description 2
- 230000028043 self proteolysis Effects 0.000 description 2
- 229910021647 smectite Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- CUVLMZNMSPJDON-UHFFFAOYSA-N 1-(1-butoxypropan-2-yloxy)propan-2-ol Chemical compound CCCCOCC(C)OCC(C)O CUVLMZNMSPJDON-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 1
- JCTXKRPTIMZBJT-UHFFFAOYSA-N 2,2,4-trimethylpentane-1,3-diol Chemical compound CC(C)C(O)C(C)(C)CO JCTXKRPTIMZBJT-UHFFFAOYSA-N 0.000 description 1
- CFPOJWPDQWJEMO-UHFFFAOYSA-N 2-(1,2-dicarboxyethoxy)butanedioic acid Chemical class OC(=O)CC(C(O)=O)OC(C(O)=O)CC(O)=O CFPOJWPDQWJEMO-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- NSMMFSKPGXCMOE-UHFFFAOYSA-N 2-[2-(2-sulfophenyl)ethenyl]benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1C=CC1=CC=CC=C1S(O)(=O)=O NSMMFSKPGXCMOE-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- GFBLJMHGHAXGNY-ZLUOBGJFSA-N Ala-Asn-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GFBLJMHGHAXGNY-ZLUOBGJFSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- HZYFHQOWCFUSOV-IMJSIDKUSA-N Asn-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O HZYFHQOWCFUSOV-IMJSIDKUSA-N 0.000 description 1
- VGRHZPNRCLAHQA-IMJSIDKUSA-N Asp-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O VGRHZPNRCLAHQA-IMJSIDKUSA-N 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
- 102220499774 Carbonic anhydrase 2_N67Q_mutation Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 102220599936 Disks large-associated protein 5_G69E_mutation Human genes 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000755093 Gaidropsarus vulgaris Species 0.000 description 1
- 102220603318 Homeobox protein SIX3_V138D_mutation Human genes 0.000 description 1
- 241000288147 Meleagris gallopavo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 102220602132 NACHT, LRR and PYD domains-containing protein 10_I209E_mutation Human genes 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 102220561519 Neuronal migration protein doublecortin_G67E_mutation Human genes 0.000 description 1
- 102220481793 Neutral amino acid transporter A_A164G_mutation Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 102220547866 Nucleobindin-1_N140Q_mutation Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102220630442 Presenilin-1_G206D_mutation Human genes 0.000 description 1
- AFWBWPCXSWUCLB-WDSKDSINSA-N Pro-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 AFWBWPCXSWUCLB-WDSKDSINSA-N 0.000 description 1
- 101710180012 Protease 7 Proteins 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 102220506702 Starch-binding domain-containing protein 1_W203A_mutation Human genes 0.000 description 1
- 102220630035 Stress-responsive DNAJB4-interacting membrane protein 1_N68Q_mutation Human genes 0.000 description 1
- 102220540204 WD repeat and coiled-coil-containing protein_T73E_mutation Human genes 0.000 description 1
- 102220506294 WD repeat-containing protein 36_Y216P_mutation Human genes 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 102220370914 c.200A>G Human genes 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 229940044172 calcium formate Drugs 0.000 description 1
- 235000019255 calcium formate Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 108010085318 carboxymethylcellulase Proteins 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- GSPKZYJPUDYKPI-UHFFFAOYSA-N diethoxy sulfate Chemical compound CCOOS(=O)(=O)OOCC GSPKZYJPUDYKPI-UHFFFAOYSA-N 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- UZABCLFSICXBCM-UHFFFAOYSA-N ethoxy hydrogen sulfate Chemical class CCOOS(O)(=O)=O UZABCLFSICXBCM-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940093476 ethylene glycol Drugs 0.000 description 1
- IFQUWYZCAGRUJN-UHFFFAOYSA-N ethylenediaminediacetic acid Chemical compound OC(=O)CNCCNCC(O)=O IFQUWYZCAGRUJN-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940060367 inert ingredients Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000012933 kinetic analysis Methods 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical class CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920002601 oligoester Polymers 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 102220196096 rs1057518583 Human genes 0.000 description 1
- 102220216845 rs1060503163 Human genes 0.000 description 1
- 102220323495 rs1170323988 Human genes 0.000 description 1
- 102200085502 rs121917883 Human genes 0.000 description 1
- 102200090690 rs137852487 Human genes 0.000 description 1
- 102220126492 rs139093654 Human genes 0.000 description 1
- 102220049864 rs587783571 Human genes 0.000 description 1
- 102200046998 rs62645894 Human genes 0.000 description 1
- 102220033203 rs62645895 Human genes 0.000 description 1
- 102220242938 rs770592607 Human genes 0.000 description 1
- 102220222692 rs775045445 Human genes 0.000 description 1
- 102220078865 rs776745618 Human genes 0.000 description 1
- 102220063385 rs786204922 Human genes 0.000 description 1
- 102220192067 rs886057201 Human genes 0.000 description 1
- 102220293166 rs918796736 Human genes 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- DZCAZXAJPZCSCU-UHFFFAOYSA-K sodium nitrilotriacetate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CC([O-])=O DZCAZXAJPZCSCU-UHFFFAOYSA-K 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical class NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
Definitions
- the present invention relates to novel enzyme variants useful in a variety of cleaning compositions, and DNA sequences encoding such enzyme variants
- Enzymes make up the largest class of naturally occurring proteins Each class of enzyme generally catalyzes (accelerates a reaction without being consumed) a different kind of chemical reaction
- One class of enzymes known as proteases are known for their ability to hydrolyze (break down a compound into two or more simpler compounds with the uptake of the H and OH parts of a water molecule on either side of the chemical bond cleaved) other proteins This ability to hydrolyze proteins has been taken advantage of by incorporating naturally occurring and protein engineered proteases as an additive to laundry detergent preparations Many stains on clothes are proteinaceous and wide-specificity proteases can substantially improve removal of such stains
- protease characteristics such as thermal stability, pH stability, oxidative stability and substrate specificity are not necessarily optimized for utilization outside the natural environment of the enzyme
- the ammo acid sequence of the protease determines the characteristics of the protease
- a change of the ammo acid sequence of the protease may alter the properties of the enzyme to varying degrees, or may even inactivate the enzyme, depending upon the location, nature and/or magnitude of the change in the ammo acid sequence
- Several approaches have been taken to alter the wild-type ammo acid sequence of proteases in an attempt to improve their properties, with the goal of increasing the efficacy of the protease in the wash environment
- These approaches include altering the am o acid sequence to enhance thermal stability and to improve oxidation stability under quite diverse conditions
- the present invention relates to Thermitase variants having a modified ammo acid sequence of wild-type Thermitase am o acid sequence, the wild-type amino acid sequence comprising a first loop region, a second loop region, a third loop region, a fourth loop region and a fifth loop region, wherein the modified am o acid sequence comprises different ammo acids than that occurring in wild-type Thermitase (i.e , substitution) at specifically identified positions in one or more of the loop regions whereby the Thermitase variant has decreased adsorption to, and increased hydrolysis of, an insoluble substrate as compared to the wild-type Thermitase
- the present invention also relates to DNA sequences encoding such Thermitase variants
- the present invention also relates to compositions comprising such Thermitase variants for cleaning a variety of surfaces.
- This invention pertains to subtilisin enzymes, in particular Thermitase, that have been modified by mutating the various nucleotide sequences that code for the enzyme, thereby modifying the amino acid sequence of the enzyme.
- the modified subtilisin enzymes (hereinafter, "Thermitase variants") of the present invention have decreased adsorption to and increased hydrolysis of an insoluble substrate as compared to the wild-type subtilisin.
- the present invention also pertains to DNA sequences encoding for such Thermitase variants.
- subtilisin enzymes of this invention belong to a class of enzymes known as proteases.
- a protease is a catalyst for the cleavage of peptide bonds
- One type of protease is a se ⁇ ne protease.
- a serme protease is distinguished by the fact that there is an essential serme residue at the active site
- the mutations described herein are designed to change (i.e., decrease) the adsorption of the enzyme to surface-bound soils
- certain amino acids form exterior loops on the enzyme molecule.
- these loops shall be referred to as first, second, third, fourth and fifth loop regions.
- positions 66- 73 form the first loop region
- positions 103-115 form the second loop region
- positions 134-141 form the third loop region
- positions 162-171 form the fourth loop region
- positions 191-195 form the fifth loop region
- positions 204-224 form the sixth loop region (position numbering analogous to positions in the amino acid sequence for wild-type subtilisin Thermitase (SEQ ID N0.1 )).
- loop regions play a significant role in the adsorption of the enzyme molecule to a surface-bound peptide, and specific mutations in one or more of these loop regions will have a significant effect on this adsorption. While not wishing to be bound by theory, it is believed that the loop regions are important to the adsorption of the Thermitase molecule for at least two reasons. First, the amino acids which comprise the loop regions can make close contacts with any surfaces to which the molecule is exposed. Second, the proximity of the loop regions to the active-site and binding pocket of the Thermitase molecule gives them a role in the catalytically productive adsorption of the enzyme to surface-bound substrates (peptides/protein soils).
- variant means an enzyme having an amino acid sequence which differs from that of wild-type.
- mutant Thermitase DNA means a DNA sequence coding for a Thermitase variant.
- wild-type Thermitase refers to an enzyme represented by SEQ ID NO:1.
- the amino acid sequence for Thermitase is further described by Meloun, B., Baudys, M., Kostka, V., Hausdorf, G., Frommel, C, and Hohne, W.E., FEBS LETT., Vol. 183, pp. 195-200 (1985), incorporated herein by reference.
- the term "Thermitase wild-type amino acid sequence” encompasses SEQ ID NO:1 as well as SEQ ID NO:1 having modifications to the amino acid sequence other than at any of positions 66, 67, 68, 69, 70, 72, 73, 103, 104, 105, 106, 107, 108, 109, 110, 111 , 112, 113, 114, 115, 134, 135, 136, 137, 138, 139, 140, 141 , 162, 163, 164, 165, 166, 167, 168, 169, 170, 171 , 191 , 192,193,194, 195, 204, 205, 206, 207, 208, 209, 210, 211 , 212, 213, 214, 215, 216, 217, 218, 219, 220, 221 , 222, 223 or 224.
- hydrophilicity table lists amino acids in descending order of increasing hydrophilicity (see Hopp, T.P., and Woods, K.R., "Prediction of Protein Antigenic Determinants from Amino Acid Sequences", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, Vol. 78, pp. 3824-3828, 1981 , incorporated herein by reference).
- Table 1 also indicates which amino acids carry a charge (this characteristic being based on a pH of from about 8-9).
- the positively charged amino acids are Arg and Lys
- the negatively charged amino acids are Glu and Asp
- the remaining amino acids are neutral.
- the substituting amino acid is either neutral or negatively charged, more preferably negatively charged (i.e., Glu or Asp).
- the statement “substitute Gin with an equally or more hydrophilic amino acid which is neutral or has a negative charge” means Gin would be substituted with Asn (which is equally hydrophilic to Gin), or Ser, Glu or Asp (which are more hydrophilic than Gin); each of which are neutral or have a negative charge, and have a greater hydrophilicity value as compared to Gin.
- the statement “substitute Pro with a more hydrophilic amino acid which is neutral or has a negative charge” means Pro would be substituted with Gin, Asn, Ser, Glu or Asp.
- the Thermitase variant has a modified amino acid sequence of Thermitase wild-type amino acid sequence, wherein the wild-type amino acid sequence comprises a substitution at one or more positions in one or more of the first loop region, the second loop region, the third loop region, the fourth loop region, the fifth loop region or the sixth loop region; whereby the Thermitase variant has decreased adsorption to, and increased hydrolysis of, an insoluble substrate as compared to the wild-type Thermitase
- the substituting ammo acid for one or more of the positions in one or more of the loop regions is with reference to Table 1 neutral or negatively charged and equally or more hydrophilic, preferably more hydrophilic, than the ammo acid at the subject position in the wild-type ammo acid sequence A Substitutions in the First Loop Region
- substitution occurs at one or more of positions 66, 67, 68, 69, 70, 72 or 73
- the substituting ammo acid is Asn, Asp, Gin, Glu, Pro or Ser
- the substituting ammo acid is Asn, Asp, Gin, Glu, Pro or Ser
- the substituting ammo acid is Asn, Asp, Gin, Glu, Pro or Ser
- the substituting ammo acid is Asn, Asp, Gin, Glu, Gly, Pro or Ser B Substitutions in the Second LOOP Region
- substitution occurs at one or more of positions 103, 104, 105, 106, 107, 108, 109, 110, 111 , 112, 113, 114 or 115
- the substituting ammo acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, Met, Pro, Ser or Thr.
- the substituting ammo acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, He, Met, Pro, Ser , Thr or Val
- the substituting ammo acid is Asp, Gin, Glu or Ser
- the substituting ammo acid is Asp or Glu.
- the substituting amino acid is Asn, Asp, Gin, Glu, Pro or Ser.
- the substituting amino acid is Asp or Glu.
- the substituting amino acid is Asn, Asp, Gin, Glu, Pro or Ser.
- the substituting amino acid is Asn, Asp, Gin, Glu, Gly, Pro or Ser.
- the substituting amino acid is Ala. Asn, Asp, Cys, Gin, Glu, Gly, His, lie, Leu, Met, Phe, Pro, Ser, Thr, Tyr or Val.
- the substituting amino acid is Asn, Asp, Gin. Glu, Gly, Pro or Ser.
- the substituting amino acid is Asn, Asp, Gin, Glu, Gly, His, Pro, Ser or Thr.
- the substituting amino acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, Met, Pro, Ser or Thr.
- substitution occurs at one or more of positions 134, 135, 136, 137, 138, 139, 140 or 141.
- the substituting amino acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, He, Met, Pro, Ser, Thr or Val.
- the substituting amino acid is Asn, Asp, Gin, Glu, Pro or Ser.
- the substituting amino acid is Asn, Asp, Gin, Glu, Pro or Ser.
- the substituting amino acid is Asn, Asp, Gin, Glu, Gly, Pro or Ser.
- the substituting amino acid is Ala, Asn, Asp, cys, Gin, Glu, Gly, His, Met, Pro, Ser or Thr.
- the substituting amino acid is Asn, Asp, Gin, Glu, Pro or Ser.
- the substituting amino acid is Asp, gin, Glu or Ser.
- substitution occurs at one or more of positions 162, 163, 164, 165, 166, 167, 168, 169, 170 or 171
- the substituting ammo acid is Asn, Asp, Gin, Glu, Pro or Ser
- the substituting ammo acid is Asp, Gin, Glu or Ser.
- the substituting ammo acid is Asn, Asp, Gin, Glu, Gly, His, Pro, Ser or Thr.
- the substituting am o acid is Asn, Asp, Gin, Glu, Pro or Ser
- the substituting ammo acid is Asp, Gin, Glu or Ser
- the substituting ammo acid is Asn, Asp, Gin, Glu, Gly, Pro or Ser
- the substituting ammo acid is Asn, Asp, Gin, Glu, Gly, His, Pro, Ser or Thr.
- the substituting ammo acid is Asn, Asp, Gin, Glu, Gly or Ser
- the substituting am o acid is Asp, Gin, Glu or Ser.
- the substituting am o acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, He, Leu, Met, Pro, Ser, Thr or Val.
- substitution occurs at one or more of positions 191 , 192, 193, 194 or 195.
- the substituting am o acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, He, Leu, Met, Pro, Ser, Thr, Tyr or Val.
- the substituting ammo acid is Asp or Glu.
- the substituting amino acid is Asn, Asp, Gin, Glu, Gly, Pro or Ser.
- substitution occurs at one or more of positions 204, 205, 206, 207, 208, 209, 210, 211 , 212, 213, 214, 215, 216, 217, 218 or 219, 220, 221 , 223 or 224.
- the substituting amino acid is Asn, Asp, Gin, Glu, Gly, His, Pro, Ser or Thr.
- the substituting amino acid is Asn, Asp, Gin, Glu, Gly or Ser.
- the substituting amino acid is Asn, Asp, Gin, Glu, Pro or Ser.
- the substituting amino acid is Asp or Glu.
- the substituting amino acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, He, Leu, Met, Phe, Pro, Ser, Thr, Tyr or Val.
- the substituting amino acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, Leu, Met, Pro, Ser, Thr or Val.
- the substituting amino acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, He, Leu, Met, Pro, Ser, Thr or Val.
- the substituting amino acid is Asp or Glu.
- the substituting amino acid is Asn, Asp, Gin, Glu, Gly, Pro or Ser.
- the substituting amino acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, He, Leu, Met, Phe, Pro, Ser, Thr or Val.
- the substituting amino acid is Asn, Asp, Gin, Glu, Gly, or Ser.
- the substituting amino acid is Asn, Asp, Gin, Glu, Gly, Pro or Ser.
- the substituting amino acid is Asp or Glu.
- the substituting amino acid is Asn Asp, Gin, Glu, Gly, Pro or Ser
- the substituting ammo acid is Ala Asn Asp, Cys Gin, Glu, Gly, His, lie, Leu, Met, Pro Ser, Thr or Val
- the substituting ammo acid is Asn, Asp, Gin, Glu, Gly, His, Pro, Ser or Thr
- the substituting ammo acid is Ala, Asn, Asp, Cys, Gin, Glu, Gly, His, He, Met, Pro, Ser, Thr or Val
- the substituting ammo acid is Asn, Asp, Gin, Glu, Pro or Ser
- the substituting ammo acid is Asn, Asp, Gin, Glu, Gly, Pro or Ser G Preparation of enzyme variants
- TP phagemid
- Thermitase gene is constructed The 2 8 Kbp Pvu II restriction enzyme fragment of plasmid pUC119, (Vieira, J and Messing, J , "Production of Single-Stranded Plasmid DNA", 153 METHODS IN ENZYMOLOGY 3-11 (1989)) is cloned into the Pvu II site of plasmid pUB110 (Bacillus Genetic Stock Center, Columbus OH 1 E9)
- the pUC119-pUB110 hybrid plasmid is named pJMA601
- Into the 8amH1 restriction site of PJMA601 is cloned the polymerase chain reaction-amplified Thermitase gene gene giving TP Phagemid TP is transformed into Escherichia coli Ung" strain CJ236 and a single stranded uracil-contaming DNA template is produced using the VCSM13 helper phage (Kunkel, T A ,
- Oligonucleotides are made using an Applied Biosystem Inc 380B DNA synthesizer Mutagenesis reaction products are transformed into Escherichia coli strain MM294 (American Type Culture Collection E. coli 33625) All mutants are confirmed by DNA sequencing and the isolated DNA is transformed into the Bacillus subtilis expression strain BG2036 (Yang, M Y., E Ferrari and D. J.
- Example 2 Fermentation The Bacillus subtilis cells (BG2036) containing a subtilisin mutant of interest are grown to mid-log phase in a one liter culture of LB-glucose broth and inoculated into a Biostat ED fermenter (B Braun Biotech, Inc., Allentown, Pennsylvania) in a total volume of 10 liters
- the fermentation media contains Yeast Extract, starch, antifoam, buffers and trace minerals (see FERMENTATION A PRACTICAL APPROACH, Ed. B McNeil and L M Harvey, 1990)
- the broth is kept at a constant pH of 7.0 during the fermentation run.
- Chloramphenical is added for antibiotic selection of mutagenized plasmid
- the cells are grown overnight at 37°C to an AQQQ of about 60 and harvested
- the fermentation broth is taken through the following steps to obtain pure enzyme
- the broth is cleared of Bacillus subtilis cells by centnfugation, and clarified by removing fine particulates with a 100K cutoff membrane This is followed by concentration on a 10K cutoff membrane, and flow dialysis to reduce the ionic strength and adjust the pH to 5 5 using 0 025M MES buffer (2-( ⁇ -morphol ⁇ no)ethanesulfon ⁇ c acid)
- the enzyme is further purified by loading it onto either a cation exchange chromatography column or an affinity adsorption chromatography column and elutmg it from the column with a NaCI or a propylene glycol gradient (see Scopes, R K , PROTEIN PURIFICATION PRINCIPLES AND PRACTICE, Sp ⁇ nger-Verlag, New York (1984), incorporated herein by reference)
- the pNA assay (DelMar, E G , C Largman, J W Brod ⁇ ck and M C Geokas, ANAL BIOCHEM , Vol 99, pp 316-320, (1979), incorporated herein by reference) is used to determine the active enzyme concentration for fractions collected during gradient elution This assay measures the rate at which p-nitroani ne is released as the enzyme hydrolyzes the soluble synthetic substrate, succinyl-alanine-alanine-prolme-phenylalanine-p- nitroani de (sAAPF-pNA) The rate of production of yellow color from the hydrolysis reaction is measured at 410 nm on a spectrophotometer and is proportional to the active enzyme concentration In addition, absorbance measurements at 280 nm are used to determine the total protein concentration The active enzyme/total-protein ratio gives the enzyme purity, and is used to identify fractions to be pooled for the stock solution
- the enzyme stock solution is eluted through a Sephadex-G25 (Pharmacia, Piscataway, New Jersey) size exclusion column to remove the propylene glycol and exchange the buffer.
- the MES buffer in the enzyme stock solution is exchanged for 0.1 M Tris buffer (Tris(hydroxymethyl-aminomethane) containing 0.01 M CaCl2 and pH adjusted to 8.6 with HCI. All experiments are carried out at pH 8.6 in Tris buffer thermostated at 25°C. H. Characterization of enzyme variants
- CPG Aminopropyl controlled pore glass
- DMSO dimethyl sulfoxide
- the CPG surface will have 62,000 ⁇ 7,000 pNA molecules/ ⁇ m 2 .
- the surface area will remain unchanged from the value of 50.0m2/g reported by CPG Inc. for the CPG as received. This suggests that the procedure used to add sAAPF-pNA to CPG does not damage the porous structure (mean diameter is 486 A).
- CPG:sAAPF-pNA Using CPG:sAAPF-pNA, adsorption of an enzyme variant and hydrolysis of a CPG-bound peptide can be measured in a single experiment. A small volume of enzyme variant stock solution is added to a flask containing Tris buffer and CPG:sAAPF-pNA which has been degassed.
- the flask is shaken on a wrist-action shaker for a period of 90 minutes during which the shaker is stopped at various time intervals (for example, every 2 minutes during the early stages of adsorption hydrolysis - e.g., the first 20 minutes - and every 10 minutes towards the end of the experiment)
- the CPG:sAAPF-pNA is allowed to settle and the solution is sampled
- enzyme adsorption can be determined by measuring solution depletion The difference between the initial enzyme variant concentration and the concentration measured at each individual time point gives the amount of enzyme variant adsorbed
- the amount of pNA hydrolyzed from the surface is measured by taking an absorbance reading on an aliquot of the sample at 410 nm
- the total amount of pNA hydrolyzed is calculated by adding the amount sampled and the amount remaining in the flask This value is corrected by subtracting the amount of pNA that is hydrolyzed by Tris buffer at pH 8.6 when no enzyme is present. This base-hydrolysis ranges from 7-29% of the total hydrolysis depending on the efficiency of the enzyme
- the rates of hydrolysis of the soluble substrate sAAPF-pNA are monitored by measuring the adsorbance increase as a function of time at 410 nm on a DU-70 spectrophotometer.
- the enzyme concentration is held constant and is prepared to be in the range of 6-10 nanomolar while the substrate concentration is varied from 90-700 ⁇ M sAAPF-pNA for each kinetic determination.
- An adsorbance data point is taken each second over a period of 900 seconds and the data are transferred to a LOTUSTM spreadsheet (Lotus Development Corporation, Cambridge, Massachusetts).
- Thermitase variants of the present invention which have decreased adsorption to and increased hydrolysis of surface bound substrates are exemplified in Tables 2-36, below.
- Tables 2-36, below the original amino acid occurring in wild-type is given first, the position number second, and the substituted amino acid third.
- Tyr218Asp 4- Leu221Asn Thr212Pro + Tyr213Ser + Thr215Asp 4- Ser216Asp +
- Ser220Asp 4- Leu221Glu + Thr224Ser Trp208Met 4- Tyr210Thr + Thr212Asn -J- Ala219Gln +
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40157395A | 1995-03-09 | 1995-03-09 | |
US401573 | 1995-03-09 | ||
PCT/US1996/003009 WO1996028558A1 (en) | 1995-03-09 | 1996-03-06 | Thermitase variants having decreased adsorption and increased hydrolysis |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0815244A1 true EP0815244A1 (en) | 1998-01-07 |
Family
ID=23588283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96908663A Withdrawn EP0815244A1 (en) | 1995-03-09 | 1996-03-06 | Thermitase variants having decreased adsorption and increased hydrolysis |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0815244A1 (zh) |
JP (1) | JPH11501816A (zh) |
CN (1) | CN1183118A (zh) |
AU (1) | AU5182996A (zh) |
BR (1) | BR9607756A (zh) |
CA (1) | CA2214578A1 (zh) |
CZ (1) | CZ280097A3 (zh) |
HU (1) | HUP9802069A3 (zh) |
IL (1) | IL117352A0 (zh) |
IN (1) | IN187236B (zh) |
MA (1) | MA23819A1 (zh) |
MX (1) | MX9706846A (zh) |
WO (1) | WO1996028558A1 (zh) |
ZA (1) | ZA961822B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997023605A1 (en) * | 1995-12-22 | 1997-07-03 | Helix Biotechnology Ltd. | Thermostable proteolytic enzyme from thermoactinomyces thalpophilus thm1 |
AU4773197A (en) * | 1996-11-04 | 1998-05-29 | Novo Nordisk A/S | Subtilase variants and compositions |
JPH10204500A (ja) * | 1997-01-20 | 1998-08-04 | Soft Kyukyu Corp:Kk | 発泡錠剤洗浄剤 |
ES2367505T3 (es) | 1997-10-23 | 2011-11-04 | Danisco Us Inc. | Variantes de proteasa con sustituciones múltiples con carga neta alterada para usar en detergentes. |
AR016969A1 (es) * | 1997-10-23 | 2001-08-01 | Procter & Gamble | VARIANTE DE PROTEASA, ADN, VECTOR DE EXPRESIoN, MICROORGANISMO HUESPED, COMPOSICIoN DE LIMPIEZA, ALIMENTO PARA ANIMALES Y COMPOSICIoN PARA TRATAR UN TEXTIL |
WO2000037627A1 (en) * | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
AU771078B2 (en) * | 1998-12-18 | 2004-03-11 | Novozymes A/S | Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in the active site loop region |
US7319112B2 (en) | 2000-07-14 | 2008-01-15 | The Procter & Gamble Co. | Non-halogenated antibacterial agents and processes for making same |
DE10153792A1 (de) | 2001-10-31 | 2003-05-22 | Henkel Kgaa | Neue Alkalische Protease-Varianten und Wasch- und Reinigungsmittel enthaltend diese neuen Alkalischen Protease-Varianten |
DE10162727A1 (de) | 2001-12-20 | 2003-07-10 | Henkel Kgaa | Neue Alkalische Protease aus Bacillus gibsonii (DSM 14391) und Wasch-und Reinigungsmittel enthaltend diese neue Alkalische Protease |
DE10162728A1 (de) | 2001-12-20 | 2003-07-10 | Henkel Kgaa | Neue Alkalische Protease aus Bacillus gibsonii (DSM 14393) und Wasch-und Reinigungsmittel enthaltend diese neue Alkalische Protease |
JP5339672B2 (ja) * | 2006-07-03 | 2013-11-13 | 小林製薬株式会社 | 漂白洗浄剤組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116741A (en) * | 1988-04-12 | 1992-05-26 | Genex Corporation | Biosynthetic uses of thermostable proteases |
JPH04500384A (ja) * | 1989-06-26 | 1992-01-23 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 酵素洗剤組成物 |
ES2227508T3 (es) * | 1989-06-26 | 2005-04-01 | Unilever N.V. | Composiciones detergentes enzimaticas. |
DK316989D0 (da) * | 1989-06-26 | 1989-06-26 | Novo Nordisk As | Enzymer |
WO1995007991A2 (en) * | 1993-09-15 | 1995-03-23 | The Procter & Gamble Company | Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
-
1996
- 1996-03-04 IL IL11735296A patent/IL117352A0/xx unknown
- 1996-03-06 CZ CZ972800A patent/CZ280097A3/cs unknown
- 1996-03-06 HU HU9802069A patent/HUP9802069A3/hu unknown
- 1996-03-06 BR BR9607756A patent/BR9607756A/pt not_active Application Discontinuation
- 1996-03-06 IN IN457DE1996 patent/IN187236B/en unknown
- 1996-03-06 JP JP8527693A patent/JPH11501816A/ja active Pending
- 1996-03-06 MX MX9706846A patent/MX9706846A/es unknown
- 1996-03-06 CN CN96193608A patent/CN1183118A/zh active Pending
- 1996-03-06 WO PCT/US1996/003009 patent/WO1996028558A1/en not_active Application Discontinuation
- 1996-03-06 AU AU51829/96A patent/AU5182996A/en not_active Abandoned
- 1996-03-06 ZA ZA961822A patent/ZA961822B/xx unknown
- 1996-03-06 EP EP96908663A patent/EP0815244A1/en not_active Withdrawn
- 1996-03-06 CA CA002214578A patent/CA2214578A1/en not_active Abandoned
- 1996-03-07 MA MA24176A patent/MA23819A1/fr unknown
Non-Patent Citations (1)
Title |
---|
See references of WO9628558A1 * |
Also Published As
Publication number | Publication date |
---|---|
HUP9802069A2 (hu) | 1998-12-28 |
HUP9802069A3 (en) | 2000-11-28 |
CZ280097A3 (cs) | 1998-01-14 |
IN187236B (zh) | 2002-03-09 |
MA23819A1 (fr) | 1996-10-01 |
WO1996028558A1 (en) | 1996-09-19 |
BR9607756A (pt) | 1999-03-30 |
ZA961822B (en) | 1996-09-11 |
IL117352A0 (en) | 1996-07-23 |
CN1183118A (zh) | 1998-05-27 |
MX9706846A (es) | 1997-11-29 |
CA2214578A1 (en) | 1996-09-19 |
JPH11501816A (ja) | 1999-02-16 |
AU5182996A (en) | 1996-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6599730B1 (en) | Subtilisin 309 variants having decreased adsorption and increased hydrolysis | |
US6436690B1 (en) | BPN′ variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted | |
EP0719339B1 (en) | Subtilisin bpn' variants with decreased adsorption and increased hydrolysis | |
US6455295B1 (en) | Subtilisin Carlsberg variants having decreased adsorption and increased hydrolysis | |
US6451574B1 (en) | Proteinase K variants having decreased adsorption and increased hydrolysis | |
EP0758373A1 (en) | Fabric cleaning compositions containing subtilisin bpn' variants | |
CA2214579C (en) | Subtilisin dy variants having decreased adsorption and increased hydrolysis | |
EP0815244A1 (en) | Thermitase variants having decreased adsorption and increased hydrolysis | |
WO1996028558A9 (en) | Thermitase variants having decreased adsorption and increased hydrolysis | |
US6440717B1 (en) | BPN′ variants having decreased adsorption and increased hydrolysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970808 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19990726 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20000705 |